- Home
- OSUR vs RCKT Comparison
OSUR vs RCKT Comparison
Compare OSUR & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSUR | RCKT |
|---|---|---|
| Founded | 2000 | 1999 |
| Country | United States | United States |
| Employees | 500 | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.7M | 239.3M |
| IPO Year | 2000 | 2014 |
Fundamental Metrics
Financial Performance| Metric | OSUR | RCKT |
|---|---|---|
| Price | $3.94 | $2.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | $5.50 | ★ $8.58 |
| AVG Volume (30 Days) | 574.1K | ★ 2.1M |
| Earning Date | 11-09-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.37 |
| EPS | N/A | ★ 0.66 |
| Revenue | ★ $167,064,000.00 | N/A |
| Revenue This Year | $5.46 | N/A |
| Revenue Next Year | $7.63 | $915.60 |
| P/E Ratio | ★ N/A | $3.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.08 | $2.17 |
| 52 Week High | $4.58 | $5.45 |
Technical Indicators
Market Signals| Indicator | OSUR | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 52.21 | 45.08 |
| Support Level | $3.89 | $2.17 |
| Resistance Level | $4.16 | $2.78 |
| Average True Range (ATR) | 0.18 | 0.18 |
| MACD | 0.02 | 0.06 |
| Stochastic Oscillator | 44.94 | 53.47 |
Price Performance
Historical ComparisonAbout OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.